147 related articles for article (PubMed ID: 1464160)
1. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
[TBL] [Abstract][Full Text] [Related]
2. Suramin blocks intracellular Ca2+ release and growth factor-induced increases in cytoplasmic free Ca2+ concentration.
Seewald MJ; Olsen RA; Powis G
Cancer Lett; 1990 Feb; 49(2):107-13. PubMed ID: 2306703
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation.
Powis G; Seewald M; Hoke M
Cancer Chemother Pharmacol; 1992; 30(6):483-6. PubMed ID: 1394806
[TBL] [Abstract][Full Text] [Related]
4. Suramin binds to platelet-derived growth factor and inhibits its biological activity.
Hosang M
J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phospholipase D by agents that inhibit cell growth.
Gratas C; Powis G
Anticancer Res; 1993; 13(4):1239-44. PubMed ID: 8352550
[TBL] [Abstract][Full Text] [Related]
6. Nonresponsiveness of an SV40-transformed Balb/c-3T3 cell line to PDGF mitogenicity is correlated with an irreversible reduction in PDGF receptor number.
Cook JR; Wang DY; Chen JK
Life Sci; 1993; 53(10):803-10. PubMed ID: 8394965
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
9. Association of increased intracellular free Ca2+ by platelet-derived growth factor with mitogenesis but not with proteoglycan synthesis in chondrocytes--effect of suramin.
Fukuo K; Morimoto S; Kaji K; Koh E; Hironaka T; Morita R; Kim S; Onishi T
Cell Calcium; 1989 Jan; 10(1):29-35. PubMed ID: 2543505
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intracellular Ca2+ signalling, cytotoxicity and antitumor activity of the herbicide oryzalin and its analogues.
Powis G; Gallegos A; Abraham RT; Ashendel CL; Zalkow LH; Dorr R; Dvorakova K; Salmon S; Harrison S; Worzalla J
Cancer Chemother Pharmacol; 1997; 41(1):22-8. PubMed ID: 9443610
[TBL] [Abstract][Full Text] [Related]
11. Activation of platelet-derived growth factor (PDGF) receptor dephosphorylation in intact Swiss 3T3 cells by elevators of intracellular Ca2+ and cAMP.
Böhmer FD; Böhmer SA
FEBS Lett; 1996 Aug; 391(1-2):219-22. PubMed ID: 8706921
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of platelet-derived growth factor-induced arachidonic acid release in Swiss 3T3 fibroblasts: the role of a localized increase in free Ca2+ concentration beneath the plasma membrane and the activation of protein kinase C.
Chow SC; Powis G
Biochim Biophys Acta; 1993 Oct; 1179(1):81-8. PubMed ID: 8399354
[TBL] [Abstract][Full Text] [Related]
13. Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells.
Bando K; Kannuki S; Rokutan K; Shouno M; Matsumoto K
Neurol Med Chir (Tokyo); 1995 Sep; 35(9):631-8. PubMed ID: 7566395
[TBL] [Abstract][Full Text] [Related]
14. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
Little PJ; Rostam MA; Piva TJ; Getachew R; Kamato D; Guidone D; Ballinger ML; Zheng W; Osman N
J Pharm Pharmacol; 2013 Jul; 65(7):1055-63. PubMed ID: 23738733
[TBL] [Abstract][Full Text] [Related]
15. Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes.
Stojilkovic SS; Vukicevic S; Luyten FP
J Bone Miner Res; 1994 May; 9(5):705-14. PubMed ID: 8053400
[TBL] [Abstract][Full Text] [Related]
16. Increase of (Ca2+ +Mg2+)-ATPase activity of renal basolateral membranes by platelet-derived growth factor through a specific receptor.
Itoh K; Morimoto S; Shiraishi T; Taniguchi K; Onishi T; Kumahara Y
Biochem Biophys Res Commun; 1988 Jun; 153(3):1315-23. PubMed ID: 2839172
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy.
Fleming TP; Matsui T; Aaronson SA
Exp Gerontol; 1992; 27(5-6):523-32. PubMed ID: 1385192
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells.
Pinzani M; Knauss TC; Pierce GF; Hsieh P; Kenney W; Dubyak GR; Abboud HE
Am J Physiol; 1991 Mar; 260(3 Pt 1):C485-91. PubMed ID: 2003575
[TBL] [Abstract][Full Text] [Related]
19. Retinyl acetate inhibits platelet-derived growth factor-induced Ca2+ signals in C3H 10T1/2 fibroblasts.
Hill TD; Boynton AL; Dean NM; Mordan LJ
J Cell Physiol; 1990 Aug; 144(2):229-36. PubMed ID: 2380253
[TBL] [Abstract][Full Text] [Related]
20. Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation.
Westphal M; Ackermann E; Hoppe J; Herrmann HD
J Neurooncol; 1991 Dec; 11(3):207-13. PubMed ID: 1668406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
